An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.
Clinical trial NCT03320876 · TERMINATED
Trial details
- NCT number
- NCT03320876
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2021-06-30
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.